相关实验视频

Updated: Jul 19, 2025

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

ATP6V1F是一种新的预后生物标志物,也是肝细胞癌的潜在免疫治疗点

Xinyao Hu¹, Dan Li², Hua Zhu³

¹Cancer Center, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, China.

BMC medical genomics

|August 16, 2023

概括

这项研究确定ATP6V1F是肝细胞癌 (HCC) 的新生物标志物. 过度表达ATP6V1F与预后不佳相关,并促进HCC细胞迁移和入侵,这表明它是潜在的治疗点.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
免疫治疗是一种免疫疗法.

背景情况:

肝细胞癌 (HCC) 由于晚期检测和有限的治疗疗效,给全球健康带来了重大挑战.
免疫疗法,特别是免疫检查点抑制剂 (ICI),对HCC有希望,但患者的反应各不相同.
确定预测性生物标志物和治疗点对于改善HCC治疗结果至关重要.

研究的目的:

研究ATP6V1F在肝细胞癌 (HCC) 中的作用.
确定ATP6V1F是否可以作为HCC的预后标志物.
探索ATP6V1F与免疫细胞透的关联及其对HCC进展的功能影响.

主要方法:

在HCC患者数据中分析ATP6V1F表达.
分析ATP6V1F表达,预后,免疫细胞透和免疫检查点之间的相关性.
在体外测试 (伤口愈合,Transwell入侵,细胞亡) 评估ATP6V1F在HCC细胞中的功能作用.

主要成果:

ATP6V1F在HCC中过度表达,并与患者预后较差有关.
增加ATP6V1F表达与增加特定免疫细胞的透和免疫检查点的表达相关.
ATP6V1F促进HCC细胞迁移和入侵,同时在体外抑制细胞亡.

结论:

ATP6V1F是一种新型瘤基因,也是HCC的潜在预后生物标志物.
向ATP6V1F可能提供一种提高HCC免疫疗法疗效的策略.
了解ATP6V1F的作用为开发针对HCC患者的精确免疫疗法提供了洞察力.

关键词:

在 ATP6V1F 中,在HCC中,HCC是HCC.免疫细胞透进入免疫细胞.免疫治疗是一种免疫疗法.在TME中,它是最重要的.

更多相关视频

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.